Plateau Systems Provides e-Learning Solution for One Of World's Largest Biotechnology Companies
Genzyme Corp. Selects Plateau's Enterprise Learning Management System to Web-enable and Manage Learning for its Employees Around the World
FAIRFAX, VA May 3, 2001 - Plateau Systems, a leading provider of integrated e-Learning solutions for global enterprises, announced today that Genzyme Corporation is implementing Plateau's Enterprise Learning Management System to manage learning for its employees.
Plateau, which already provides enterprise-class learning solutions for healthcare and pharmaceutical and medical device manufacturers such as Guidant, Alza and Aventis, will initially be installing software to meet the required training needs of more than 1,500 Genzyme employees in Eastern Massachusetts.
In a second phase, Genzyme plans to implement Plateau's open-architecture Enterprise Learning Management System to support online learning activities, certification testing and training management for more than 3,000 employees around the world.
Genzyme Corp. is an international biotechnology company that has three divisions across the world specializing in therapeutics for genetic diseases and other chronic disorders, biosurgery, and cancer therapies. All of Genzyme's units will be integrated into Plateau's e-Learning management system.
- Genzyme plans to use Plateau's ELMS to:
- Help comply with Good Manufacturing Practice regulations
- Automatically update Standard Operating Procedures training
- Eliminate manual data downloads for students
- Generate training assignments by job title that are automatically revised as employees take on new job positions
- Provide a comprehensive audit trail of its training history
- Help comply with federal Food and Drug Administration training guidelines
"Being selected by a company with Genzyme's global reach and complex training needs reinforces Plateau's reputation as a leader in enterprise learning management," said Paul Sparta, Plateau's Chairman and Chief Executive Officer. "No other company in our industry can provide a solution that better manages, tracks, revises and provides assessments for millions of learning records."
Plateau's Enterprise Learning Management System (ELMS) is a core platform that extends an enterprise's knowledge base to all of its corners, providing the ability to instantly deploy learning when and where it is needed. It seamlessly integrates with Human Resource Information Systems, Enterprise Resource Planning and other enterprise software assets, and supports critical business applications such as for-profit learning portals and tailored ASP-based solutions.
Plateau recently received $18 million in venture equity to rapidly expand its sales and marketing force and enhance its suite of e-Learning solutions. The privately held company already provides comprehensive learning management systems for some of the world's leading enterprises, from Federal Express to Motorola University.
About Plateau Systems: Plateau manages learning and knowledge processes for organizations, improving their business operations by integrating and delivering the knowledge employees, customers and partners require to excel. Plateau's enterprise-class software supports online and traditional learning methods, and integrates seamlessly with other enterprise software applications to enhance their value and reduce the cycle of learning. Plateau 4 Learning Management System (LMS) is built on open, J2EE/EJB architecture, and is being used by clients across the globe, including Motorola University, Federal Express, Nestle USA and the U.S. Air Force. The company was founded in 1996, and is headquartered in Arlington, Virginia.
About Genzyme Corp: Genzyme Corporation is a biotechnology company that develops and markets innovative products and services for unmet medical needs. With three divisions, each targeting a specific area of expertise, Genzyme Corporation combines the resources and strengths of one of the world's largest biotechnology companies with the entrepreneurial spirit and dedication of focused, flexible, and independent businesses. Genzyme uses a wide range of technologies in its research and development efforts. With a strong international infrastructure, including extensive capabilities in sales and marketing, manufacturing, and regulatory affairs, Genzyme has a successful track record in working closely with patients and physicians. The company has three divisions: Genzyme Biosurgery, Genzyme General, and Genzyme Molecular Oncology. Genzyme Corporation has issued a separate series of common stock that is designed to reflect the value of each division.
###